190 related articles for article (PubMed ID: 23597957)
1. [Economic analysis of the treatment of heart failure with beta-blockers].
Díez-Manglano J
Med Clin (Barc); 2013 Sep; 141(6):265-70. PubMed ID: 23597957
[No Abstract] [Full Text] [Related]
2. [Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
Díez Manglano J
Rev Clin Esp; 2005 Apr; 205(4):149-56. PubMed ID: 15860185
[TBL] [Abstract][Full Text] [Related]
3. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
Whorlow SL; Krum H
Am J Cardiol; 2000 Oct; 86(8):886-9. PubMed ID: 11024409
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada.
Levy AR; Briggs AH; Demers C; O'Brien BJ
Am Heart J; 2001 Sep; 142(3):537-43. PubMed ID: 11526370
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of beta blockade in heart failure.
Gregory D; Udelson JE; Konstam MA
Am J Med; 2001 May; 110 Suppl 7A():74S-80S. PubMed ID: 11334781
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
8. Top heart failure drugs compared.
Health News; 2003 Sep; 9(9):6-7. PubMed ID: 14584471
[No Abstract] [Full Text] [Related]
9. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
Goldstein S; Gottlieb SS
J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
[TBL] [Abstract][Full Text] [Related]
10. A cost-effectiveness analysis of bisoprolol for heart failure.
Varney S
Eur J Heart Fail; 2001 Jun; 3(3):365-71. PubMed ID: 11378009
[TBL] [Abstract][Full Text] [Related]
11. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
Wikstrand J; Wedel H; Castagno D; McMurray JJ
J Intern Med; 2014 Feb; 275(2):134-43. PubMed ID: 24118421
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of beta-blocker treatment in heart failure.
Gilbert EM
Rev Cardiovasc Med; 2002; 3 Suppl 3():S42-7. PubMed ID: 12447161
[TBL] [Abstract][Full Text] [Related]
13. Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model.
Yao G; Freemantle N; Flather M; Tharmanathan P; Coats A; Poole-Wilson PA;
Pharmacoeconomics; 2008; 26(10):879-89. PubMed ID: 18793034
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of beta blocker therapy for patients with chronic severe heart failure in Ireland.
Barry M
Ir Med J; 2002 Jun; 95(6):174, 176-7. PubMed ID: 12171265
[TBL] [Abstract][Full Text] [Related]
15. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
vom Dahl J; Schotten U; Sasse A
Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
[No Abstract] [Full Text] [Related]
16. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
DiNicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH
Am J Cardiol; 2013 Mar; 111(5):765-9. PubMed ID: 23290925
[TBL] [Abstract][Full Text] [Related]
17. Beta blockers and congestive heart failure.
Movahed A
Am Fam Physician; 2000 Dec; 62(11):2402-4. PubMed ID: 11130228
[No Abstract] [Full Text] [Related]
18. Which beta-blocker for heart failure?
Patel MR; Gattis W
Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
[No Abstract] [Full Text] [Related]
19. Beta-blockers for heart failure: why you should use them more.
Ong HT; Kow FP
J Fam Pract; 2011 Aug; 60(8):472-7. PubMed ID: 21814642
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.
Patel RS; Sharma KH; Kamath NA; Patel NH; Thakkar AM
Indian J Pharmacol; 2014; 46(5):485-9. PubMed ID: 25298575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
